Insight Molecular Diagnostics's total assets for Q4 2025 were $25.76M, a decrease of -41.38% from the previous quarter. IMDX total liabilities were $57.22M for the fiscal quarter, a 7.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.